Literature DB >> 4314307

The effect of an interferon inducer on influenza virus.

D A Hill, S Baron, R M Chanock.   

Abstract

The double-stranded complex of polyriboinosinic acid and polyribocytidilic acid (poly I.poly C) was shown to inhibit effectively the infection of human cells with 4 common human respiratory pathogens-influenza A2, rhinovirus 13, respiratory syncytial and parainfluenza-1 viruses. This protection was observed with levels of poly I.poly C which did not induce the release of detectable amounts of interferon. Mice could be protected from pulmonary influenza A2 infections by intranasal instillation of poly I.poly C before challenge with virus. Administration of poly I.poly C directly to the respiratory tract was found superior to systemic administration in the case of the pulmonary infection studied.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4314307      PMCID: PMC2427755     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

Review 1.  MECHANISM OF RECOVERY FROM VIRAL INFECTION.

Authors:  S BARON
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

2.  Inducers of interferon and host resistance, V. In vitro studies.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

3.  Induction of the interferon system by various inducers.

Authors:  C E Buckler; K T Wong; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

4.  Role of interferon during viremia. II. Protective action of circulating interferon.

Authors:  S Baron; C E Buckler; R M Friedman; R V McCloskey
Journal:  J Immunol       Date:  1966-01       Impact factor: 5.422

5.  Sensitivity of common respiratory viruses to an interferon inducer in human cells.

Authors:  D A Hill; S Baron; R M Chanock
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

6.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

7.  Interferon in mice: protection against small doses of virus.

Authors:  N B Finter
Journal:  J Gen Virol       Date:  1967-07       Impact factor: 3.891

8.  EXPERIMENTAL INFECTION WITH INFLUENZA A VIRUS IN MICE : THE INCREASE IN INTRAPULMONARY VIRUS AFTER INOCULATION AND THE INFLUENCE OF VARIOUS FACTORS THEREON.

Authors:  R M Taylor
Journal:  J Exp Med       Date:  1941-01-01       Impact factor: 14.307

  8 in total
  6 in total

Review 1.  The contribution of virology to contemporary medicine.

Authors:  C Stuart-Harris
Journal:  Br J Prev Soc Med       Date:  1975-03

2.  Antiviral and interferon-inducing activity of a new glutarimide antibiotic, 9-methylstreptimidone.

Authors:  N Saito; F Suzuki; K Sasaki; N Ishida
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

3.  Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice.

Authors:  G P Khare; R W Sidwell; J T Witkowski; L N Simon; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

4.  Inhibition of influenza virus and interferon response intranasally with statolon.

Authors:  W J Kleinschmidt; F Streightoff
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

5.  BMAL1 links the circadian clock to viral airway pathology and asthma phenotypes.

Authors:  A Ehlers; W Xie; E Agapov; S Brown; D Steinberg; R Tidwell; G Sajol; R Schutz; R Weaver; H Yu; M Castro; L B Bacharier; X Wang; M J Holtzman; J A Haspel
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 6.  Towards the Application of Human Defensins as Antivirals.

Authors:  Mee Sook Park; Jin Il Kim; Ilseob Lee; Sehee Park; Joon-Yong Bae; Man-Seong Park
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.